Study

HBOT can alleviate fibromyalgia syndrome

The study investigates the effects of hyperbaric oxygen therapy (HBOT) on telomere length and immune response in isolated blood cells.

Lesezeit:

10

min.

Hyperbaric Oxygen Therapy (HBOT): Can It Slow Aging and Promote Health? New Study Reveals Surprising Benefits

Have you heard about hyperbaric oxygen therapy (HBOT) and its potential health benefits? Recent scientific research shows that HBOT may do more than support wound healing—it could even slow aging at the cellular level and strengthen the immune system.

What is Hyperbaric Oxygen Therapy (HBOT)?

During HBOT, patients breathe pure oxygen inside a pressurized chamber. This allows significantly more oxygen to enter the body compared to normal breathing, promoting healing and regeneration in tissues.

The Groundbreaking Study: HBOT, Telomeres, and the Immune System

A clinical study published in 2020 in the journal Aging examined the effects of HBOT on cellular aging and the immune system. The research team, led by Dr. Shai Efrati, treated healthy adults with multiple HBOT sessions and analyzed their blood samples.

Key Findings

Significant telomere lengthening:
Telomeres are the protective caps at the ends of our chromosomes—like the plastic tips on shoelaces. They shorten with age, contributing to aging and disease. After 60 HBOT sessions, participants showed up to 38% longer telomeres in blood cells, suggesting a potential slowing of cellular aging.

Reduction in immunosenescence:
Immunosenescence refers to the “aging” of the immune system, which weakens the body’s defenses. The study found a marked decrease in these aging immune cells—indicating that HBOT may help rejuvenate immune function.

What Do These Findings Mean for Health and Aging?

These results suggest that HBOT could have applications beyond specialized medical treatments, including:

  • Slowing down cellular aging

  • Strengthening the immune system

  • Potentially supporting chronic disease management

HBOT and Fibromyalgia

While the study described was conducted in healthy adults, other research has shown promising results for fibromyalgia, a chronic pain condition. Patients treated with HBOT reported reduced pain and improved quality of life. This may be linked to the therapy’s anti-inflammatory and regenerative effects.

Original Study on PubMed

For more scientific details, see the official PubMed entry:
Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial (PubMed ID: 33206062)

Conclusion

Hyperbaric oxygen therapy shows great promise in slowing cellular aging, boosting the immune system, and positively impacting chronic conditions such as fibromyalgia. Further research will help determine how, and in whom, the greatest benefits can be achieved.

⚠️ Important: Always consult your physician before considering new treatments like HBOT, as individual factors play a crucial role in safety and effectiveness.

Autoren

Hachmo Y; Hadanny A; Abu Hamed R; Daniel-Kotovsky M; Catalogna M; Fishlev G; Lang E; Polak N; Doenyas K; Friedman M; Zemel Y; Bechor Y; Efrati S

Publikations Details

Studientyp:

Prospektive, einarmige Interventionsstudie (Prä-Post)

Publikation:

Aging (Albany NY) 2020; 12(22):

Teilnehmer:

35 eingeschlossen; 30 abgeschlossen; je nach Analyse n≈20–25

Ort:

Shamir (Assaf-Harofeh) Medical Center / Sagol Center for Hyperbaric Medicine and Research, Israel

Seiten:

22445–22456

22445–22456

DOI:

10.18632/aging.202188

10.18632/aging.202188

PubMed ID:

33206062

33206062

Auf PubMed öffnen

Weitere Studien und Ressourcen finden Sie hier.

Weitere Studien und Ressourcen finden Sie hier.

Weiterlesen